Enzyme inhibitors
Catalog | Product Name / CAS / Description | Structure |
---|---|---|
BBF-01188 |
Dykellic acid (1097679-78-1) Inquiry |
|
It is produced by the strain of Westerdykella multispora F50733. It is an immunologically active substance. It can strongly inhibit LPS-induced B cell proliferation and the production of B cell polyclonal IgM antibody, as well as T cell proliferation. The expression of IL-2 and IL-4 genes in Th cells was inhibited. |
||
BBF-01206 |
Elsinochrome A (24568-67-0) Inquiry |
|
It is produced by the strain of Elsinoe annonae, Sphaceloma randii. It's the same as Hypericin, it has photodynamic activity and inhibits protein kinase C activity. |
||
BBF-01207 |
Elsinochrome B (24512-58-1) Inquiry |
|
It is produced by the strain of Elsinoe annonae, Sphaceloma randii. It's the same as Hypericin, it has photodynamic activity and inhibits protein kinase C activity. |
||
BBF-01208 |
Elsinochrome C (24512-87-6) Inquiry |
|
It is produced by the strain of Elsinoe annonae, Sphaceloma randii. It's the same as Hypericin, it has photodynamic activity and inhibits protein kinase C activity. |
||
BBF-01209 |
Elsinochrome D (32500-05-3) Inquiry |
|
It is produced by the strain of Elsinoe annonae, Sphaceloma randii. It's the same as Hypericin, it has photodynamic activity and inhibits protein kinase C activity. |
||
BBF-01241 |
Epi-cochlioquinone A (147384-57-4) Inquiry |
|
It is produced by the strain of Stachybitrys bisbyi. It can inhibit rat liver microsomal ACAT with IC50 of 1.7 μmol/L, inhibit plasma lecithin cholesterol acyltransferase (LCAT) with IC50 of 15.8 μmol/L, and inhibit cholesterol absorption in rats by 50% at 75 mg/kg. |
||
BBF-01244 |
Gibbestatin B (89687-34-3) Inquiry |
|
It is produced by the strain of Streptomyces sp. C39. Gibbestatin B inhibits the expression of α-amylase induced by gibberellin in De-embryoned rice and barley (IC50 is 25-50 ppm, IC100 is 100-200 ppm), and has no anti-bacterial, anti-yeast and anti-fungal effects at 100 ppm (MIC, agar dilution method using bouillon agar for bacteria and Sabouraud agar for yeast and fungi). |
||
BBF-01253 |
Glisoprenin A (144376-62-5) Inquiry |
|
It is produced by the strain of Gliocladium sp. FO-1513. It is a cholesterol acyltransferase (ACAT) inhibitor, and it can inhibit the formation of Appressorium on the hydrophobic surface of Magnaporthegrisea. |
||
BBF-01254 |
Glisoprenin B (144376-63-6) Inquiry |
|
It is produced by the strain of Gliocladium sp. FO-1513. It is a cholesterol acyltransferase (ACAT) inhibitor. |
||
BBF-01255 |
Glisoprenin C (205594-88-3) Inquiry |
|
It is produced by the strain of Gliocladium roseum HA190-95. It is a cholesterol acyltransferase (ACAT) inhibitor, and it can inhibit the formation of Appressorium on the hydrophobic surface of Magnaporthegrisea. |
||
BBF-01256 | ||
It is produced by the strain of Gliocladium roseum HA190-95. It is a cholesterol acyltransferase (ACAT) inhibitor, and it can inhibit the formation of Appressorium on the hydrophobic surface of Magnaporthegrisea. |
||
BBF-01257 | ||
It is produced by the strain of Gliocladium roseum HA190-95. It is a cholesterol acyltransferase (ACAT) inhibitor, and it can inhibit the formation of Appressorium on the hydrophobic surface of Magnaporthegrisea. |
||
BBF-01260 |
Glucoallosamidin A (136236-41-4) Inquiry |
|
Glucoallosamidin A is a glycoside antibiotic produced by the strain of Streptomyces sp. SA-684. It can inhibit Chitinase activity. |
||
BBF-01261 |
Glucoallosamidin B (136236-42-5) Inquiry |
|
Glucoallosamidin B is a glycoside antibiotic produced by the strain of Streptomyces sp. SA-684. It can inhibit Chitinase activity. |
||
BBF-01262 |
Glucolipsin A (222613-92-5) Inquiry |
|
It is produced by the strain of Streptomyces purpurogeniscleroticus WC 71634, Nocardia vaccinii WC 65712. It is a glucokinase activator. It can reactivate the glucokinase inhibited by FAC with RC50 of 5.4 μmol/L. |
||
BBF-01263 |
Glucolipsin B (222613-93-6) Inquiry |
|
It is produced by the strain of Streptomyces purpurogeniscleroticus WC 71634, Nocardia vaccinii WC 65712. It is a glucokinase activator. It can reactivate the glucokinase inhibited by FAC with RC50 of 4.6 μmol/L. |
||
BBF-01285 |
Griseolic acid A (79030-08-3) Inquiry |
|
It is produced by the strain of Streptomyces griseoaurantiacus SANK43894. It has the activity of inhibiting cyclic adenosine monophosphate (cAMP) phosphodiesterase [EC 3.1.4.17] with IC50 0.16 X 10-6 mol/L (Extracted from rat brain). Griseolic acid A can stimulate the flow of glycogen and increase the blood sugar level in mice. |
||
BBF-01286 |
Griseolic acid B (98890-01-8) Inquiry |
|
It is produced by the strain of Streptomyces griseoaurantiacus SANK43894. It has the activity of inhibiting cyclic adenosine monophosphate (cAMP) phosphodiesterase [EC 3.1.4.17] with IC50 0.16 X 10-6 mol/L (Extracted from rat brain). |
||
BBF-01287 |
Griseolic acid C (100242-49-7) Inquiry |
|
It is produced by the strain of Streptomyces griseoaurantiacus SANK43894. It has the activity of inhibiting cyclic adenosine monophosphate (cAMP) phosphodiesterase [EC 3.1.4.17] with IC50 0.12 X 10-6 mol/L (Extracted from rat brain). |
||
BBF-01301 | ||
It is produced by the strain of Nannizzia gypsea var. incurvata IFO 9228. It can inhibit acylcoenzyme A, cholesterol acyltransferase (ACAT) activity, inhibit rat liver microbody ACAT with IC50 of 18 μmol/L, and its action is competitive with oleoyl-COA substrate, Ki value is 5.5 μmol/L. It also inhibits [14C] oleic acid from forming cholesterol esters with IC50 of 0.65 μmol/L. |